Tag: Shreekanth Katti
Jumping through hoops
Foreign-owned Indian companies face hardships in making mandatory CSR contributions to NGOs
Overstepping the mark
The requirement to submit a test licence in the drugs and cosmetics rules goes beyond the ambit of the Parent Act, and is a hindrance to R&D for pharma companies, writes Syngene International's Shreekanth Katti
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
Wealth in transition
An unprecedented transfer of private wealth is colliding with tighter regulation and rising complexity
